Cardiac Sarcoplasmic Reticulum Calcium Cycling Proteins
心脏肌浆网钙循环蛋白
基本信息
- 批准号:6872511
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:calcium binding proteincalcium channelcalcium fluxcalcium transporting ATPaseenzyme activitygene targetinggenetically modified animalsheart contractionheart enlargementheart failureheart metabolismlaboratory mouseneuromuscular transmissionphenotypephosphatase inhibitorphospholambanphosphorylationsarcoplasmic reticulumstoichiometry
项目摘要
DESCRIPTION (provided by applicant): The depressed Ca-cycling in animal models of heart failure and human failing hearts has been suggested to reflect, at least in part, the impaired Ca-cycling by the sarcoplasmic reticulum (SR). There are three major functions of the SR: a) Ca-uptake from the cytosol into the SR lumen resulting in muscle relaxation; b) Ca-storage in the SR lumen; and c) Ca-release from the SR into the cytosol resulting in muscle contraction. The main SR proteins responsible for these functions are: the Ca-transport ATPase (SERCA2) with its regulator phospholamban (PLN); the Ca-storage proteins, calsequestrin and a histidine rich Ca-binding protein (HRC); and the Ca-release ensemble composed of the ryanodine receptor, junctin and triadin. In this project, we propose further studies on elucidating the regulatory role of increased (chronic or acute) PLN phosphorylation, through regulation of its phosphatase 1 activity by Inhibitor-I, in the control of contractility and the heart's responses to stress. Furthermore, since alterations in the degree of PLN phosphorylation reflect alterations in SR Ca-load and release, we propose to elucidate the functional roles of: a) SR Ca load through calsequestrin, the major Ca storage protein in the SR lumen; and b) SR Ca-release through junctin, one of the major proteins in the release cassette. Animal models with reduced or ablated expression of calsequestrin or junctin will be generated and their cardiac phenotypes will be analyzed at the molecular, subcellular, cellular, organ and intact animal levels under basal and stress conditions. These studies will provide important information on the functional role of calsequestrin and junctin in vivo under physiological and pathophysiological conditions. Overall, our proposed studies will advance our knowledge on the mechanisms underlying regulation of Ca homeostasis by the SR function in the mammalian heart. They will also provide valuable insights into the crosstalk between the various SR Ca handling proteins and their regulatory effects on cardiac contractility.
描述(申请人提供):在心力衰竭和人类心力衰竭的动物模型中,钙循环的抑制至少部分地反映了肌浆网(SR)对钙循环的损害。SR有三个主要功能:a)胞浆中的钙摄取到SR腔内,导致肌肉松弛;b)SR腔内的钙储存;c)SR中的Ca释放到胞浆中,导致肌肉收缩。负责这些功能的主要SR蛋白是:钙转运ATPase(SERCA2)及其调节因子磷蛋白(PLN);钙储存蛋白、钙库蛋白和富含组氨酸的钙结合蛋白(HRC);以及由兰诺定受体、连接素和Triadin组成的钙释放系统。在这个项目中,我们建议进一步研究PLN磷酸化增加(慢性或急性),通过抑制物-I调节其磷酸酶1的活性,在控制收缩能力和心脏对应激的反应中发挥调节作用。此外,由于PLN磷酸化程度的改变反映了SR钙负荷和释放的变化,我们建议阐明以下功能:a)通过SR腔中主要的钙储存蛋白Calequestrin来装载SR Ca;b)通过释放盒中的主要蛋白质之一Junctin来释放SR Ca。在基础和应激条件下,将建立钙调素或连接素表达减少或消融的动物模型,并在分子、亚细胞、细胞、器官和完整动物水平上分析其心脏表型。这些研究将为钙调素和连接素在生理和病理生理条件下在体内的功能作用提供重要的信息。总体而言,我们提出的研究将促进我们对哺乳动物心脏SR功能调节钙稳态的潜在机制的了解。他们还将提供有价值的见解,以了解不同的SR钙处理蛋白之间的串扰及其对心脏收缩能力的调节作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Evangelia G Kranias其他文献
Unleashing the Power of Genetics: PLN Ablation, Phospholambanopathies and Evolving Challenges.
释放遗传学的力量:PLN 消融、磷酸化病和不断变化的挑战。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:20.1
- 作者:
Alicia Mattiazzi;Evangelia G Kranias - 通讯作者:
Evangelia G Kranias
Physiologic and Molecular Changes Reflecting Impaired Calcium Cycling in Pacing Induced Heart Failure in Immature Goats ♦ 83
反映未成熟山羊起搏诱发心力衰竭中钙循环受损的生理和分子变化♦83
- DOI:
10.1203/00006450-199804001-00104 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Anirban Banerjee;Sonali Shah;Preeti Joshi;Marjorie Gabel;Brain D Hoit;Evangelia G Kranias - 通讯作者:
Evangelia G Kranias
Delayed Restitution of Contractility Reflects Impaired Calcium Handling in Pacing Induced Heart Failure in Immature Goats
收缩功能延迟恢复反映了未成熟山羊起搏诱导心力衰竭中钙处理受损
- DOI:
10.1203/00006450-199904020-00119 - 发表时间:
1999-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Anirban Banerjee;Preeti Joshi;Judy M Harrer;Evangelia G Kranias;Brian D Hoit - 通讯作者:
Brian D Hoit
Altered Atrial Function and Associated Changes in Proteins Responsible for Myocardial Contraction and Relaxation in Right Atria of Children With Tetralogy of Fallot • 84
法洛四联症患儿右心房心房功能改变及与心肌收缩和舒张相关蛋白的变化 • 84
- DOI:
10.1203/00006450-199804001-00105 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Anirban Banerjee;Dimple P Shah;Vivek J Kadambi;Peter B Manning;Evangelia G Kranias - 通讯作者:
Evangelia G Kranias
Evangelia G Kranias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Evangelia G Kranias', 18)}}的其他基金
Calcium Cycling Protein Mutations in Human Heart Failure
人类心力衰竭中的钙循环蛋白突变
- 批准号:
7338017 - 财政年份:2007
- 资助金额:
$ 38.38万 - 项目类别:
Calcium Cycling Protein Mutations in Human Heart Failure
人类心力衰竭中的钙循环蛋白突变
- 批准号:
7312576 - 财政年份:2006
- 资助金额:
$ 38.38万 - 项目类别:
Calcium Cycling Protein Mutations in Human Heart Failure
人类心力衰竭中的钙循环蛋白突变
- 批准号:
6892776 - 财政年份:2005
- 资助金额:
$ 38.38万 - 项目类别:
Genetic and Molecular Signaling in Heart Failure
心力衰竭的遗传和分子信号传导
- 批准号:
7564000 - 财政年份:2005
- 资助金额:
$ 38.38万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 38.38万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别: